Hendrie H C, Ogunniyi A, Hall K S, Baiyewu O, Unverzagt F W, Gureje O, Gao S, Evans R M, Ogunseyinde A O, Adeyinka A O, Musick B, Hui S L
Department of Psychiatry, Indiana University School of Medicine, 541 Clinical Dr, Room 394A, Indianapolis, IN 46202, USA.
JAMA. 2001 Feb 14;285(6):739-47. doi: 10.1001/jama.285.6.739.
Alzheimer disease (AD) represents a major and increasing public health problem. If populations were identified with significantly lower or higher incidence rates of AD, the search for risk factors in the genesis of AD could be greatly enhanced.
To compare incidence rates of dementia and AD in 2 diverse, elderly community-dwelling populations.
The Indianapolis-Ibadan Dementia Project, a longitudinal, prospective population-based study consisting of a baseline survey (1992-1993) and 2 subsequent follow-up waves after 2 years (1994-1995) and 5 years (1997-1998). Each wave followed a 2-stage design, with an in-home screening interview followed by a full diagnostic workup of a subsample of participants based on screening performance.
A total of 2459 community-dwelling Yoruba residents of Ibadan, Nigeria, without dementia, and 2147 community-dwelling African American residents of Indianapolis, Ind, without dementia (all aged 65 years or older). The cohorts were followed up for a mean of 5.1 years and 4.7 years, respectively.
Incident cases of dementia and AD in each of the 2 populations.
The age-standardized annual incidence rates were significantly lower among Yoruba than among African Americans for dementia (Yoruba, 1.35% [95% confidence interval [CI], 1.13%-1.56%]; African Americans, 3.24% [95% CI, 2.11%-4.38%]) and for AD (Yoruba, 1.15% [95% CI, 0.96%-1.35%]; African Americans, 2.52% [95% CI, 1.40%-3.64%]).
This is the first report of incidence rate differences for dementia and AD in studies of 2 populations from nonindustrialized and industrialized countries using identical methods and the same group of investigators in both sites. Further explorations of these population differences may identify potentially modifiable environmental or genetic factors to account for site differences in dementia and AD.
阿尔茨海默病(AD)是一个日益严重的重大公共卫生问题。如果能确定AD发病率显著较低或较高的人群,那么对AD发病风险因素的研究将会得到极大加强。
比较两个不同的老年社区居住人群中痴呆症和AD的发病率。
印第安纳波利斯-伊巴丹痴呆症项目,这是一项基于人群的纵向前瞻性研究,包括一次基线调查(1992 - 1993年)以及随后2年(1994 - 1995年)和5年(1997 - 1998年)的两次随访。每次随访采用两阶段设计,先进行一次居家筛查访谈,然后根据筛查结果对部分参与者进行全面诊断检查。
共有2459名居住在尼日利亚伊巴丹社区且无痴呆症的约鲁巴居民,以及2147名居住在印第安纳州印第安纳波利斯社区且无痴呆症的非裔美国居民(均为65岁及以上)。两个队列的随访时间平均分别为5.1年和4.7年。
两个群体中痴呆症和AD的发病病例。
约鲁巴人群中痴呆症(约鲁巴人,1.35%[95%置信区间(CI),1.13% - 1.56%];非裔美国人,3.24%[95%CI,2.11% - 4.38%])和AD(约鲁巴人,1.15%[95%CI,0.96% - 1.35%];非裔美国人,2.52%[95%CI,1.40% - 3.64%])的年龄标准化年发病率显著低于非裔美国人。
这是首次使用相同方法且由同一组研究人员在非工业化国家和工业化国家的两项研究中报告痴呆症和AD发病率差异的研究。对这些人群差异的进一步探索可能会确定潜在的可改变环境或遗传因素,以解释痴呆症和AD的地区差异。